FDA seeks Comments on Ways to Avoid Gluten in Drug Products
The Food and Drug Administration is seeking comments and information that will assist it in its deliberations about ways to help individuals with celiac disease avoid the presence of gluten in drug products. In particular, FDA is interested in information…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
on ingredients present in human drug products marketed in the U.S. that are currently derived from wheat, barley, or rye. Comments are due by February 21, 2012.